Barclays Reiterates "Equal Weight" Rating for Astera Labs (NASDAQ:ALAB)

Key Points

• Barclays reaffirmed its "equal weight" rating for Astera Labs, setting a price target of $155.00, indicating a potential downside of 3.00% from the current price.
• Astera Labs recently reported a significant quarterly revenue increase of 149.5% year-over-year, with an EPS of $0.44 that surpassed analyst estimates.
• Insider trading activity was notable, with the CEO and CFO selling shares valued at over $20 million combined, reflecting a decrease in their positions in the company.

Astera Labs (NASDAQ:ALAB - Get Free Report)'s stock had its "equal weight" rating reaffirmed by research analysts at Barclays in a report released on Monday,Benzinga reports. They presently have a $155.00 price objective on the stock. Barclays's price target would indicate a potential downside of 3.00% from the company's current price.

Several other research firms also recently weighed in on ALAB. Citigroup boosted their target price on shares of Astera Labs from $160.00 to $275.00 and gave the stock a "buy" rating in a research report on Wednesday, September 17th. Northland Securities cut shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price objective for the company. in a research report on Tuesday, July 22nd. Northland Capmk cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. CICC Research started coverage on shares of Astera Labs in a research report on Friday, August 29th. They set an "outperform" rating and a $190.00 price objective for the company. Finally, Zacks Research cut shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 6th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $162.06.

Astera Labs Stock Down 2.3%

Shares of Astera Labs stock opened at $159.80 on Monday. The firm's 50 day moving average price is $199.68 and its 200-day moving average price is $128.80. Astera Labs has a 52-week low of $47.13 and a 52-week high of $262.90. The company has a market cap of $26.56 billion, a P/E ratio of 285.36, a PEG ratio of 3.98 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the previous year, the firm earned $0.13 EPS. The company's quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts forecast that Astera Labs will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 91,441 shares of the company's stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief executive officer owned 2,170,877 shares in the company, valued at $398,377,638.27. This represents a 4.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael Truett Tate sold 18,861 shares of the company's stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $3,461,182.11. Following the transaction, the chief financial officer owned 259,512 shares of the company's stock, valued at approximately $47,623,047.12. The trade was a 6.78% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,092,997 shares of company stock worth $192,231,120. 12.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Astera Labs

A number of large investors have recently bought and sold shares of ALAB. Great Valley Advisor Group Inc. grew its position in shares of Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company's stock worth $372,000 after buying an additional 90 shares in the last quarter. Straight Path Wealth Management boosted its holdings in Astera Labs by 1.5% in the second quarter. Straight Path Wealth Management now owns 6,850 shares of the company's stock worth $619,000 after purchasing an additional 100 shares during the period. First Horizon Advisors Inc. boosted its holdings in Astera Labs by 12.4% in the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company's stock worth $89,000 after purchasing an additional 108 shares during the period. Advisors Asset Management Inc. boosted its holdings in Astera Labs by 68.6% in the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company's stock worth $43,000 after purchasing an additional 194 shares during the period. Finally, Berbice Capital Management LLC boosted its holdings in Astera Labs by 14.3% in the second quarter. Berbice Capital Management LLC now owns 1,600 shares of the company's stock worth $145,000 after purchasing an additional 200 shares during the period. Hedge funds and other institutional investors own 60.47% of the company's stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.